GlassScriptPhysician profile
Gordon D Burtch
NPI 1457344277
$3,959.65
in general payments reported to CMS, 2019-2025
28 companies · $51.32 in 2025
The $51.32 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $454 · 2020: $609 · 2021: $1,195 · 2022: $695 · 2023: $843 · 2024: $112 · 2025: $51.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,006.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,227.03 | 2019-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Aaa Endoprosthesis, Gore Excluder Iliac Branch Endoprosthesis |
| Boston Scientific Corporation | $822.91 | 2019-2023 | Varithena Administration Pack |
| Janssen Pharmaceuticals, INC | $288.74 | 2019-2022 | |
| Philips North America LLC | $233.13 | 2020 | |
| Medtronic Vascular, INC. | $191.94 | 2019-2020 | |
| Intact Vascular, INC. | $150.00 | 2019 | |
| Integra Lifesciences Corporation | $133.63 | 2022-2023 | Medihoney, Biodfactor, Biodrestore |
| Getinge USA Sales, LLC | $123.35 | 2021 | |
| Innocoll Pharmaceuticals Limited | $110.56 | 2021-2022 | |
| Cardiva Medical, INC. | $101.21 | 2022 | |
| Cvrx, INC. | $87.42 | 2021-2023 | Barostim Neo System |
| Mozarc Medical US LLC | $53.23 | 2023 | Palindrome |
| Cook Medical LLC | $51.46 | 2020 | |
| Inari Medical, INC. | $49.20 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Angiodynamics, INC. | $44.09 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $41.15 | 2019-2024 | Artegraft Vascular Graft |
| Cardinal Health 200 LLC | $34.71 | 2019-2020 | |
| Davol INC. | $29.67 | 2019 | |
| Pfizer INC. | $23.68 | 2020-2021 | |
| Silk Road Medical, INC. | $23.26 | 2021-2022 | |
| Baxter Healthcare | $23.13 | 2021 | |
| Kci USA, INC. | $22.48 | 2022 | |
| Tactile Systems Technology INC | $21.98 | 2025 | Flexitouch Plus, Nimbl |
| Ethicon US, LLC | $17.49 | 2020 | |
| Allergan, INC. | $16.76 | 2021 | |
| Cordis US Corp. | $12.82 | 2022 | |
| Kerecis Limited | $12.38 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Organogenesis INC. | $12.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gordon Burtch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.